Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating diabetes with FGF21 and GLP1 double gene-modified cell

Method of treating diabetes with FGF21 and GLP1 double gene-modified cell

US Patent 12414966 · Granted Sep 16, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

System and method for battery selection2025
Battery module lithium plating reduction2025
State of charge dependent plating estimation and prevention2025
Method for quickly optimizing key mining parameters of outburst coal seam2024
Methods for obtaining and correcting biological sequence information2024
Cooling strategy for battery systems2024
Methods for obtaining and correcting biological sequence information2023
State of charge dependent plating estimation and prevention2023
Method for preparing an Fe-tCDTA contrast agent and product obtainable by the me2023
FGF21 and GLP1 double gene-modified mesenchymal stem cell and use in treating a 2023
FGF21 and GLP1 double gene-modified mesenchymal stem cell and use in treating a 2023
FGF21 and GLP1 double gene-modified mesenchymal stem cell and use in treating a 2023